Clinical Trials Browser

Phase 1 × Erlotinib Hydrochloride × Other neoplasm × Clear all

NCT00566800 2013-09-17

Erlotinib in Treating Patients With Barrett Esophagus

Phase 1 Unknown

GastrointestinalOther neoplasm

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions